PE anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PE_Pos_071006.jpg
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_A_PE_Pos_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
  • N418_B_PE_Neg_071006.jpg
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE N418 (top) or PE Armenian hamster IgG isotype control (bottom)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
117307 50 µg 58€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117308 200 µg 147€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  2. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  3. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  4. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  5. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  6. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  7. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  8. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  9. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  10. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  11. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  12. Fan L, et al. 2021. Cancers (Basel). 13:. PubMed
  13. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  14. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  15. Naito Y, et al. 2019. American Journal of Physiology-Renal Physiology. 318(1):F238-F247. PubMed
  16. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  17. Tseng K, et al. 2009. J Immunol. 182:4590. PubMed
  18. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  19. Kang S, et al. 2009. Gastroenterology. 137:1391. PubMed
  20. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  21. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  22. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  23. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  24. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  25. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  26. Cheong SS, et al. 2020. Front Cell Dev Biol. 8:577201. PubMed
  27. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  28. Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed
  29. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  30. Hu K, et al. 2015. PLoS One. 10: 0137123. PubMed
  31. Toivonen R, et al. 2016. J Immunol. 196: 4750 - 4759. PubMed
  32. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  33. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  34. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  35. Nakagawa S et al. 2017. Cell host & microbe. 22(5):667-677 . PubMed
  36. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  37. Lees JG, et al. 2020. PLoS One. 15:e0238164. PubMed
  38. Li X, et al. 2015. J Immunol. 195: 2710-2721. PubMed
  39. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  40. Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed
  41. Tran L, et al. 2017. Cancer Immunol Res. 5:1141. PubMed
  42. Wang C, et al. 2017. J Immunol. 10.4049/jimmunol.1700671. PubMed
  43. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  44. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  45. Ma Y, et al. 2015. J Immunol. 195: 3769 - 3780. PubMed
  46. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  47. Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
  48. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  49. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  50. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  51. Zhang L, et al. 2021. J Immunother Cancer. 9:. PubMed
  52. Li Z, et al. 2022. J Exp Clin Cancer Res. 41:74. PubMed
  53. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  54. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  55. Jeong SH, et al. 2021. Nat Commun. 12:4405. PubMed
  56. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  57. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  58. Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed
  59. Benechet AP, et al. 2019. Nature. 574:200. PubMed
  60. Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
  61. Park SG, et al. 2021. J Vet Sci. 22:e16. PubMed
  62. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  63. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  64. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  65. Guo Y, et al. 2022. Nat Commun. 13:6534. PubMed
  66. Ray A, et al. 2015. PLoS One. 10: 0137314. PubMed
  67. Galvani E, et al. 2020. Nat Commun. 11:853. PubMed
  68. Ding Y, et al. 2022. Cell Death Dis. 13:996. PubMed
  69. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  70. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  71. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  72. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  73. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  74. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  75. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  76. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  77. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  78. Vorselen D, et al. 2021. Elife. 10:. PubMed
  79. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  80. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  81. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  82. De Simone G, et al. 2021. Immunity. :. PubMed
  83. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  84. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  85. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  86. Yang H, et al. 2019. J Neuroinflammation. 16:169. PubMed
  87. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  88. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  89. Koikawa K, et al. 2021. Cell. 184:4753. PubMed
  90. Hanihara-Tatsuzawa F, et al. 2014. J Biol Chem. 389:30925. PubMed
  91. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  92. López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed
  93. Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
  94. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  95. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  96. Benhamron S, et al. 2012. PLoS One. 7:e35602. PubMed
  97. Hsu Y, et al. 2017. Biochem Biophys Res Commun.. 10.1016/j.bbrc.2017.10.067. PubMed
  98. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  99. Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed
  100. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  101. Takahashi F, et al. 2022. iScience. 25:104278. PubMed
  102. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  103. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  104. Bi CS, et al. 2020. Cell Prolif. 53:e12827. PubMed
  105. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  106. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  107. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  108. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  109. Tuong ZK, et al. 2021. Cell Rep. 37:110132. PubMed
  110. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  111. Al-Barwani F, et al. 2014. PLoS One. 9:104523. PubMed
  112. Holzki J, et al. 2015. J Virol. 89: 9886 - 9895. PubMed
  113. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  114. Younes AI, et al. 2021. Transl Oncol. 14:100983. PubMed
  115. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  116. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  117. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  118. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  119. Lu X, et al. 2019. Circ Res. 125:1055. PubMed
  120. Godwin MS, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 320:L393. PubMed
  121. Gu H, et al. 2021. Elife. 10:. PubMed
  122. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  123. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  124. Yuan C, et al. 2015. Biochem Biophys Res Commun. 464: 249-255. PubMed
  125. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  126. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  127. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  128. Manifold-Wheeler B, et al. 2016. J Immunol. 196: 328 - 335. PubMed
  129. Zhou H, et al. 2016. J Immunol. 197: 288 - 295. PubMed
  130. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  131. Lai JH, et al. 2021. iScience. 24(6):102498. PubMed
  132. Bussey KA, et al. 2019. J Virol. 93. PubMed
  133. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  134. Melgert B, et al. 2010. Am J Respir Cell Mol Biol. 42:595. PubMed
  135. Park C, et al. 2012. J Leukoc Biol. 91:739. PubMed
  136. Hao L, et al. 2021. Br J Pharmacol. 178:4726. PubMed
  137. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  138. Siolas D, et al. 2021. Cell Reports. 36:109578. PubMed
  139. Iwai H, et al. 2015. Tuberculosis (Edinb). 95:246. PubMed
  140. Sharma M, et al. 2019. Immunometabolism. 1. PubMed
  141. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
  142. Jones GS, et al. 2020. mSphere. 5:. PubMed
  143. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  144. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  145. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  146. Tian T, et al. 2020. Cancer Immunol Res. 660:8. PubMed
  147. Mangal JL, et al. 2020. J Mater Chem B. 8:5195. PubMed
  148. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  149. Mino T, et al. 2019. Nucleic Acids Res. 47:8838. PubMed
  150. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  151. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  152. Li C, et al. 2022. Front Cell Dev Biol. 10:913824. PubMed
  153. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  154. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  155. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  156. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  157. Vecchiola A, et al. 2020. Front Endocrinol (Lausanne). 11:223. PubMed
  158. Giles DA, et al. 2018. J Clin Invest. 128:5322. PubMed
  159. Yamamoto R, et al. 2019. J Immunol. 203:167. PubMed
  160. Omenetti S, et al. 2019. Immunity. 51:77. PubMed
  161. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  162. Syed I et al. 2018. Cell metabolism. 27(2):419-427 . PubMed
RRID
AB_313776 (BioLegend Cat. No. 117307)
AB_313777 (BioLegend Cat. No. 117308)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account